Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
    • Education
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

August 25, 2015; 85 (8) Article

Comment: Chemoradiotherapy for glioblastoma patients—The double-edged sword

Lynne P. Taylor
First published July 24, 2015, DOI: https://doi.org/10.1212/WNL.0000000000001863
Lynne P. Taylor
From Virginia Mason Medical Center, Seattle, WA; University of Washington, Seattle; and Tufts University School of Medicine, Boston, MA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Comment: Chemoradiotherapy for glioblastoma patients—The double-edged sword
Lynne P. Taylor
Neurology Aug 2015, 85 (8) 689; DOI: 10.1212/WNL.0000000000001863

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
108

Share

  • Article
  • Info & Disclosures
Loading

Article Information

vol. 85 no. 8 689
DOI: 
https://doi.org/10.1212/WNL.0000000000001863
PubMed: 
26208963

Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published July 24, 2015.

Article Versions

  • Previous version (July 24, 2015 - 13:00).
  • You are viewing the most recent version of this article.
Copyright & Usage: 
© 2015 American Academy of Neurology

Author Disclosures

    1. Lynne P. Taylor, MD
  1. Lynne P. Taylor, MD
  2. Scientific Advisory Boards:
    1. NONE

    Gifts:
    1. NONE

    Funding for Travel or Speaker Honoraria:
    1. NONE

    Editorial Boards:
    1. Neurology Now, Editorial Advisory Board, 2007-present

    Patents:
    1. NONE

    Publishing Royalties:
    1. NONE

    Employment, Commercial Entity:
    1. Director of Neuro-Oncology Virginia Mason Medical Center X7-NEU, 1100 9th Avenue Seattle, WA 98101

    Consultancies:
    1. NONE

    Speakers' Bureaus:
    1. NONE

    Other Activities:
    1. NONE

    Clinical Procedures or Imaging Studies:
    1. NONE

    Research Support, Commercial Entities:
    1. NONE

    Research Support, Government Entities:
    1. NONE

    Research Support, Academic Entities:
    1. NONE

    Research Support, Foundations and Societies:
    1. NONE

    Stock/Stock Options/Board of Directors Compensation:
    1. NONE

    License Fee Payments, Technology or Inventions:
    1. NONE

    Royalty Payments, Technology or Inventions:
    1. NONE

    Stock/Stock Options, Research Sponsor:
    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:
    1. NONE

    Legal Proceedings:
    1. NONE

  1. From Virginia Mason Medical Center, Seattle, WA; University of Washington, Seattle; and Tufts University School of Medicine, Boston, MA.
View Full Text

Article usage

Article usage: July 2015 to May 2022

AbstractFullPdfSource
Jul 2015174044Highwire
Aug 20153542233Highwire
Sep 2015162711Highwire
Oct 20154414Highwire
Nov 20154711Highwire
Dec 20153500Highwire
Jan 20162711Highwire
Feb 20163312Highwire
Mar 20161610Highwire
Apr 20162500Highwire
May 20161241Highwire
Jun 20163301Highwire
Jul 20161910Highwire
Aug 20162600Highwire
Sep 20161610Highwire
Oct 20162100Highwire
Nov 20161701Highwire
Dec 20162302Highwire
Jan 20172310Highwire
Feb 20171211Highwire
Mar 20171700Highwire
Apr 20171800Highwire
May 20171200Highwire
Jun 2017700Highwire
Jul 2017810Highwire
Aug 2017800Highwire
Sep 2017700Highwire
Oct 2017400Highwire
Nov 2017101Highwire
Dec 20171500Highwire
Jan 2018300Highwire
Feb 2018800Highwire
Mar 2018501Highwire
Apr 2018500Highwire
May 2018600Highwire
Jun 2018401Highwire
Jul 2018400Highwire
Aug 2018600Highwire
Sep 2018300Highwire
Oct 2018100Highwire
Nov 2018200Highwire
Dec 2018700Highwire
Jan 2019600Highwire
Feb 20192900Highwire
Mar 201912600Highwire
Apr 201914000Highwire
May 201910311Highwire
Jun 201915500Highwire
Jul 201928710Highwire
Aug 201951800Highwire
Sep 201950200Highwire
Oct 201948300Highwire
Nov 201931600Highwire
Dec 201916810Highwire
Jan 2020700Highwire
Feb 2020800Highwire
Mar 2020500Highwire
Apr 2020200Highwire
May 2020200Highwire
Jun 2020200Highwire
Jul 2020200Highwire
Aug 2020700Highwire
Sep 2020830Highwire
Oct 20202510Highwire
Nov 2020810Highwire
Dec 2020300Highwire
Jan 2021311Highwire
Feb 2021900Highwire
Mar 2021700Highwire
Apr 2021300Highwire
May 2021610Highwire
Jun 2021200Highwire
Jul 2021800Highwire
Aug 20212000Highwire
Sep 2021611Highwire
Oct 20211500Highwire
Nov 20211600Highwire
Dec 20211000Highwire
Jan 2022200Highwire
Feb 20221500Highwire
Mar 2022500Highwire
Apr 20221600Highwire
May 20221000Highwire

Cited By...

  • 1 Citations
  • Google Scholar

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Footnotes
    • References
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

  • All Oncology
  • Outcome research
  • Clinical trials Observational study (Cohort, Case control)
  • Chemotherapy-tumor
  • Radiation therapy-tumor

Alert Me

  • Alert me when eletters are published
Neurology: 98 (24)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • Neurology: Education
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2022 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise